PTK2 and breast cancer: ORI has been reported to significantly inhibit lung tumour metastasis through anti-angiogenesis by blocking Notch signalling; it also inhibits tumour invasion and metastasis in vitro possibly by decreasing the expression of MMPs and regulating the Integrin β1/FAK pathway in human breast cancer MDA-MB-231 cells.